Detalhe da pesquisa
1.
Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network.
Dermatology
; 238(3): 498-506, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34474414